Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 480,500
-53,500 (-10.02%)
At close: Oct 8, 2026
Hanmi Pharm. Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Hanmi Pharm. stock has a consensus rating of "Buy" and an average price target of ₩664,545. The average 1-year stock price forecast is 38.30% higher than the current stock price, while the lowest is ₩560,000 (+16.55%) and the highest is ₩760,000 (+58.17%).
Price Target: ₩664,545 (+38.30%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hanmi Pharm. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 6 | 6 | 5 | 5 |
| Buy | 8 | 7 | 6 | 5 | 6 | 6 |
| Hold | 1 | 1 | 0 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 13 | 12 | 12 | 11 | 11 |
Financial Forecast
Revenue This Year
1.77T
from 1.55T
Increased by 14.11%
Revenue Next Year
1.76T
from 1.77T
Decreased by -0.31%
EPS This Year
16.99K
from 13.36K
Increased by 27.12%
EPS Next Year
17.38K
from 16.99K
Increased by 2.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.